• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新发突变介导一种机会性人类肺部病原体的表型转换。

De novo mutations mediate phenotypic switching in an opportunistic human lung pathogen.

作者信息

Poret Alexandra J, Schaefers Matthew, Merakou Christina, Mansour Kathryn E, Ahern Connor D, Lagoudas Georgia K, Haynes Alyssa, Cross Ashley R, Goldberg Joanna B, Kishony Roy, Uluer Ahmet Z, McAdam Alexander J, Blainey Paul C, Vargas Sara O, Lieberman Tami D, Priebe Gregory P

机构信息

Institute for Medical Engineering and Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.

Department of Civil and Environmental Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.

出版信息

Nat Commun. 2025 Jul 23;16(1):6799. doi: 10.1038/s41467-025-61168-4.

DOI:10.1038/s41467-025-61168-4
PMID:40701980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12287342/
Abstract

Bacteria evolving within human hosts encounter selective tradeoffs that render mutations adaptive in one context and deleterious in another. Here, we report that the cystic fibrosis-associated pathogen Burkholderia dolosa overcomes in-human selective tradeoffs by acquiring successive point mutations that alternate phenotypes. We sequenced the whole genomes of 931 respiratory isolates from two recently infected cystic fibrosis patients and an epidemiologically-linked, chronically-infected patient. These isolates are contextualized using 112 historical genomes from the same outbreak strain. Within both newly infected patients, convergent mutations that disrupt O-antigen expression quickly arose, comprising 29% and 63% of their B. dolosa communities by 3 years. The selection for loss of O-antigen starkly contrasts with our previous observation of parallel O-antigen-restoring mutations after many years of chronic infection in the historical outbreak. Experimental characterization reveals that O-antigen loss increases uptake in immune cells while decreasing competitiveness in the mouse lung. We propose that the balance of these pressures, and thus whether O-antigen expression is advantageous, depends on tissue localization and infection duration. These results suggest that mutation-driven phenotypic alternation may be underestimated without dense temporal sampling, particularly for microbes with prolonged infection or colonization.

摘要

在人类宿主内进化的细菌会面临选择性权衡,使得突变在一种情况下具有适应性,而在另一种情况下则具有有害性。在此,我们报告囊性纤维化相关病原体多氏伯克霍尔德菌通过获得交替改变表型的连续点突变,克服了在人体内的选择性权衡。我们对来自两名近期感染的囊性纤维化患者以及一名有流行病学关联的慢性感染患者的931份呼吸道分离株进行了全基因组测序。这些分离株使用来自同一暴发菌株的112个历史基因组进行背景分析。在两名新感染患者中,破坏O抗原表达的趋同突变迅速出现,到3年时分别占其多氏伯克霍尔德菌群的29%和63%。对O抗原缺失的选择与我们之前在历史暴发中对慢性感染多年后平行出现的O抗原恢复突变的观察形成鲜明对比。实验表征表明,O抗原缺失增加了在免疫细胞中的摄取,同时降低了在小鼠肺部的竞争力。我们提出,这些压力的平衡,以及因此O抗原表达是否有利,取决于组织定位和感染持续时间。这些结果表明,如果没有密集的时间采样,突变驱动的表型交替可能被低估,特别是对于具有长期感染或定植的微生物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2c/12287342/1a2d73c1a4ff/41467_2025_61168_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2c/12287342/6efc6668916c/41467_2025_61168_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2c/12287342/2b56bd99fa60/41467_2025_61168_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2c/12287342/34edf3802177/41467_2025_61168_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2c/12287342/71ddae4f6526/41467_2025_61168_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2c/12287342/1a2d73c1a4ff/41467_2025_61168_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2c/12287342/6efc6668916c/41467_2025_61168_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2c/12287342/2b56bd99fa60/41467_2025_61168_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2c/12287342/34edf3802177/41467_2025_61168_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2c/12287342/71ddae4f6526/41467_2025_61168_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2c/12287342/1a2d73c1a4ff/41467_2025_61168_Fig5_HTML.jpg

相似文献

1
De novo mutations mediate phenotypic switching in an opportunistic human lung pathogen.新发突变介导一种机会性人类肺部病原体的表型转换。
Nat Commun. 2025 Jul 23;16(1):6799. doi: 10.1038/s41467-025-61168-4.
2
mutations mediate phenotypic switching in an opportunistic human lung pathogen.突变在一种机会性人类肺部病原体中介导表型转换。
bioRxiv. 2024 Feb 6:2024.02.06.579193. doi: 10.1101/2024.02.06.579193.
3
Long-Term Evolution of during a Chronic Cystic Fibrosis Infection Reveals Shifting Forces of Selection.慢性囊性纤维化感染期间[具体对象未提及]的长期演变揭示了不断变化的选择力量。
mSystems. 2016 May 24;1(3). doi: 10.1128/mSystems.00029-16. eCollection 2016 May-Jun.
4
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039.
5
Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.囊性纤维化患者中洋葱伯克霍尔德菌复合群的根除治疗。
Cochrane Database Syst Rev. 2016 Nov 2;11:CD009876. doi: 10.1002/14651858.CD009876.pub3.
6
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.根除囊性纤维化患者体内铜绿假单胞菌的抗生素策略。
Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD004197. doi: 10.1002/14651858.CD004197.pub5.
7
Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.针对囊性纤维化患者的洋葱伯克霍尔德菌复合群根除疗法。
Cochrane Database Syst Rev. 2014 Oct 24(10):CD009876. doi: 10.1002/14651858.CD009876.pub2.
8
Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.囊性纤维化患者肺部病情加重时针对洋葱伯克霍尔德菌复合群的抗生素治疗
Cochrane Database Syst Rev. 2012 Oct 17;10:CD009529. doi: 10.1002/14651858.CD009529.pub2.
9
Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.对患有囊性纤维化且肺部病情加重的患者使用抗生素治疗洋葱伯克霍尔德菌复合体。
Cochrane Database Syst Rev. 2016 Jan 20;2016(1):CD009529. doi: 10.1002/14651858.CD009529.pub3.
10
Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.常规胸部物理治疗与其他气道清除技术在囊性纤维化中的比较。
Cochrane Database Syst Rev. 2023 May 5;5(5):CD002011. doi: 10.1002/14651858.CD002011.pub3.

引用本文的文献

1
Unmasking Pathogen Traits for Chronic Colonization in Neurogenic Bladder Patients.揭示神经源性膀胱患者慢性定植的病原体特征
bioRxiv. 2025 Aug 14:2025.08.14.669717. doi: 10.1101/2025.08.14.669717.
2
Reversions mask the contribution of adaptive evolution in microbiomes.回复突变掩盖了微生物群落中适应性进化的作用。
bioRxiv. 2024 Jun 18:2023.09.14.557751. doi: 10.1101/2023.09.14.557751.

本文引用的文献

1
Reversions mask the contribution of adaptive evolution in microbiomes.回复突变掩盖了微生物组中适应性进化的贡献。
Elife. 2024 Sep 6;13:e93146. doi: 10.7554/eLife.93146.
2
On-person adaptive evolution of Staphylococcus aureus during treatment for atopic dermatitis.金黄色葡萄球菌在特应性皮炎治疗过程中的个体适应性进化。
Cell Host Microbe. 2023 Apr 12;31(4):593-603.e7. doi: 10.1016/j.chom.2023.03.009.
3
Detecting bacterial adaptation within individual microbiomes.检测个体微生物组内的细菌适应性。
Philos Trans R Soc Lond B Biol Sci. 2022 Oct 10;377(1861):20210243. doi: 10.1098/rstb.2021.0243. Epub 2022 Aug 22.
4
Adaptation to novel spatially-structured environments is driven by the capsule and alters virulence-associated traits.适应新的空间结构环境是由荚膜驱动的,并改变了与毒力相关的特征。
Nat Commun. 2022 Aug 13;13(1):4751. doi: 10.1038/s41467-022-32504-9.
5
Reversion is most likely under high mutation supply when compensatory mutations do not fully restore fitness costs.当补偿性突变不能完全恢复适应代价时,回复突变最有可能在高突变供应下发生。
G3 (Bethesda). 2022 Aug 25;12(9). doi: 10.1093/g3journal/jkac190.
6
Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections.抗生素耐药性突变在急性细菌性呼吸道感染治疗过程中的快速扩张和消失。
Nat Commun. 2022 Mar 9;13(1):1231. doi: 10.1038/s41467-022-28188-w.
7
Interactions Between Pathogenic and the Complement System: A Review of Potential Immune Evasion Mechanisms.病原体与补体系统的相互作用:潜在免疫逃避机制的综述。
Front Cell Infect Microbiol. 2021 Sep 30;11:701362. doi: 10.3389/fcimb.2021.701362. eCollection 2021.
8
Bacterial evolution during human infection: Adapt and live or adapt and die.细菌在人体感染期间的进化:适应并生存,或适应并死亡。
PLoS Pathog. 2021 Sep 9;17(9):e1009872. doi: 10.1371/journal.ppat.1009872. eCollection 2021 Sep.
9
Evolution towards Virulence in a Two-Component System.向双组分系统毒力进化。
mBio. 2021 Aug 31;12(4):e0182321. doi: 10.1128/mBio.01823-21. Epub 2021 Aug 10.
10
Elevated rates of horizontal gene transfer in the industrialized human microbiome.工业化人类微生物组中水平基因转移率的升高。
Cell. 2021 Apr 15;184(8):2053-2067.e18. doi: 10.1016/j.cell.2021.02.052. Epub 2021 Mar 31.